✦ LIBER ✦

The influence of non-clinical patient factors on medical oncologists’ decisions to recommend breast cancer adjuvant chemotherapy

✍ Scribed by T. May Pini, Sarah T. Hawley, Yun Li, Steven J. Katz, Jennifer J. Griggs

Book ID: 113062521
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 226 KB
Volume: 134
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-012-2116-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

0133 A survey of oncologists on the dura

0133 A survey of oncologists on the duration of adjuvant aromatase inhibitor therapy - factors that influence treatment decisions in early breast cancer

✍ M.L. Citron; D.D. Amakye; R. Chlebowski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Decision-making from multidisciplinary t

Decision-making from multidisciplinary team meetings to the bedside: Factors influencing the recruitment of breast cancer patients into clinical trials

✍ Mazouni, Chafika; Deneuve, Jacqueline; Arnedos, Monica; Prenois, Fanny; Saghatch 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 201 KB

36 Oncologists', physicians' and surgeon

36 Oncologists', physicians' and surgeons' opinions on the perceived value and appropriateness of the speciality to inform patients on adjuvant chemotherapy after radical surgery for non-small cell lung cancer

✍ Tai, F.W.D.; Khor, K.S.; Popat, S.; Beckles, M.; Leung, M.; Lim, E. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 42 KB

The influence of classical prognostic fa

The influence of classical prognostic factors and adjuvant chemotherapy on disease outcome in early grade 3 node-negative, and 1–3 node-positive breast cancer patients treated with adjuvant cyclophosphamide, methotrexate and fluorouracil (CMF), or untreated patients

✍ S Susnjar; I Kezic; Z Neskovic-Konstantinovic; D Gavrilovic; D Nikolic-Vukosavlj 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

9017 POSTER DISCUSSION Initial Detection

9017 POSTER DISCUSSION Initial Detection of the Double Epidermal Growth Factor Receptor (EGFR) Mutation (L858R or Deletion in Exon 19 [del 19] Plus T790M) in Non-Small-Cell Lung Cancer (NSCLC) Patients (p) With Brain Metastases (mets) and the Influence of First-Line Chemotherapy on Outcome to Erlotinib

✍ Rolfo, C.; Moran, T.; Sanchez, J.; Molina-Vila, M.; Bertran-Alamilllo, J.; Camps 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB